MENU
GNOM
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS
Global X Genomics & Biotechnology ETF (GNOM) Ownership - Who owns Global X Genomics & Biotechnology ETF?
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index")... Show more
Category: #Health
Profile
Category
Health
Address
Global X Funds600 Lexington Avenue, 20th FloorNew York
Phone
+1 8884938631
Web
www.globalxfunds.com
Details
Group
Domestic Stock Funds
Category
Health
Net Assets
56948404.00
Fund Existence
almost 6 years
Turnover
18.89
Capitalization
N/A
Yield
N/A
Total Expense Ratio
0.50
Investment Style
N/A
Risk (Beta)
1.30
Fundamentals
GNOM
Net Assets
56.9M
Yield
0.00
Fund Existence
almost 6 years
Total Expense Ratio
0.50
Turnover
18.89
Investment Style
N/A
Capitalization
N/A
Risk (Beta)
1.30
Manager Tenure
N/A
Administrative Fee
N/A
Annual Report Gross Expense Ratio
0.50
Assets in Top Ten Holdings
45.9M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
56.9M
Fund Type
ETF
Index Fund
Yes
Management Fee
0.50
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
41.00
Number of Net Holdings
41.00
Number of Short Holdings
N/A
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
46.56%
Gain YTD
-9.681
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Category Health
Profile
Fundamentals
Details
Category
Health
Address
Global X Funds600 Lexington Avenue, 20th FloorNew York
Phone
+1 8884938631
Web
www.globalxfunds.com